Autism Clinic for Translational Research, Brain and Mind Centre, Central Clinical School, Faculty of Medicine, University of Sydney, Camperdown, Sydney, NSW 2050 Australia.
Autism Clinic for Translational Research, Brain and Mind Centre, Central Clinical School, Faculty of Medicine, University of Sydney, Camperdown, Sydney, NSW 2050 Australia.
Psychiatry Res. 2019 Jun;276:45-55. doi: 10.1016/j.psychres.2019.03.037. Epub 2019 Mar 26.
Social functioning is an important component of mental disorders for assessment and treatment. There is no recognised self-report instrument to measure social functioning across disorders where social impairment is significant. The Social Functioning Scale (SFS) has, however, been used to assess social functioning in psychotic disorders, including Schizophrenia and Early Psychosis. The current study investigated the reliability, validity and sensitivity of the SFS in Early Psychosis, Autism Spectrum Disorder (ASD), Social Anxiety Disorder (SAD) and neurotypical control populations. As expected, all clinical groups showed significant impairment on the total and sub-scale scores of the SFS. The SFS showed good internal consistency and concurrent validity for people diagnosed with SAD and Early Psychosis and a similar factors structure was found for these groups. Participants with ASD reported a relatively low internal consistency and poor concurrent validity, as well as a three-component solution. The SFS has also showed a good sensitivity to separate clinical populations and neurotypical controls. This study supports the use of the SFS for those with SAD and Early Psychosis. Lower internal consistency in ASD populations suggests further research in larger samples is required and that the relationship between its scales are likely different to other populations. Alternative scales or significant other reports may be required for adults with ASD.
社会功能是精神障碍评估和治疗的一个重要组成部分。目前还没有公认的自评工具可以测量社会功能障碍,而社会功能障碍在精神障碍中非常显著。然而,社会功能量表(SFS)已被用于评估精神分裂症和早期精神病等精神障碍中的社会功能。本研究旨在调查 SFS 在早期精神病、自闭症谱系障碍(ASD)、社交焦虑障碍(SAD)和神经典型对照组中的信度、效度和敏感性。正如预期的那样,所有临床组在 SFS 的总分和子量表得分上都表现出显著的障碍。SFS 在 SAD 和早期精神病患者中具有良好的内部一致性和同时效度,并且在这些组中发现了相似的因素结构。ASD 患者报告的内部一致性和同时效度较差,以及三成分解决方案。SFS 还对不同的临床人群和神经典型对照组具有较好的敏感性。这项研究支持将 SFS 用于 SAD 和早期精神病患者。ASD 人群中的内部一致性较低表明需要在更大的样本中进行进一步研究,并且其量表之间的关系可能与其他人群不同。对于 ASD 患者,可能需要替代量表或重要他人报告。